THE WORLD is on the cusp of a tussle between the need to urgently provide new treatments options for depression and the importance of thoroughly evaluating them before approval. With these words, Vidita Vaidya, a neuroscientist and professor at Mumbai’s Tata Institute of Fundamental Research, captured the essence of the global discourse on the use of controversial substances called psychedelics (a class of hallucinogens) in treating mental health problems. Vaidya was speaking at a science conference in Gurugram, Haryana, on February 24, 2024. “India, too, needs clinical trials to understand how these substances work and their potential risks,” she said.
Psychedelics are drugs that induce states of altered perception, behaviour, consciousness and thought, often with increased awareness of the senses. Though they belong to the same class psychotropic as other drugs for mental health problems, they seem to work better (see 'A class of its own'). Since about 30 per cent of the patients do not respond to current medications, as per a 2019 paper in BMC Psychiatry, psychedelics are increasingly being explored in some countries as alternate therapy for depression, anxiety, post-traumatic stress disorder (PTSD) and other mental health problems. As Vaidya notes, there is burning need for new treatments for depression, which is pushing governments to move quickly. So far, Australia, Canada, Denmark, Israel and a few states in the US (Oregon and Colorado) have allowed use of psychedelics for medicinal use.
A CLASS OF ITS OWN
What are psychedelic drugs and how are they different from other medicines that treat mental health problem
Bu hikaye Down To Earth dergisinin May 01, 2024 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Giriş Yap
Bu hikaye Down To Earth dergisinin May 01, 2024 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Giriş Yap
In leading role again
MOVIES AND WEB SERIES ARE ONCE AGAIN BEING SET IN RUSTIC BACKGROUNDS, INDICATING A RECONNECT BETWEEN CINEMA AND THE COUNTRYSIDE
One Nation One Subscription comes at a huge cost
As top US universities scrap big deals with top scientific publishers, India’s ONOS scheme seems flawed and outdated
Return of Rambhog
Bid to revive and sell the aromatic indigenous paddy variety has led to substantial profits for farmers in Uttar Pradesh's Terai region
Scarred by mining
Natural springs of Kashmir drying up due to illegal riverbed mining
Human-to-human spread a mutation away
CANADA IN mid-November confirmed its first human case of avian influenza, with a teenager in the British Columbia being hospitalised after contracting the H5N1 virus that causes the disease. The patient developed a severe form of the disease, also called bird flu, and had respiratory issues. There was no known cause of transmission.
True rehabilitation
Residents of Madhya Pradesh's Kakdi village take relocation as an opportunity to undertake afforestation, develop sustainable practices
INESCAPABLE THREAT
Chemical pollution is the most underrated and underreported risk of the 21st century that threatens all species and regions
THAT NIGHT, 40 YEARS AGO
Bhopal gas disaster is a tragedy that people continue to face
A JOKE, INDEED
A CONFERENCE OF IRRESPONSIBLE PARTIES THAT CREATED AN OPTICAL ILLUSION TO THE REALITY OF A NEW CLIMATE
THINGS FALL APART
THE WORLD HAS MADE PROGRESS IN MITIGATING EMISSIONS AND ADAPTING TO CLIMATE IMPACTS. BUT THE PROGRESS REMAINS GROSSLY INADEQUATE
